Market Cap 148.41B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.40
Forward PE 8.60
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 42,028,800
Avg Vol 35,172,695
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 28%
Beta 0.34
Analysts Sell
Price Target $29.28

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 9 at 5:03 AM
$SLS Fact: $ABBV or $PFE or $LLY - whoever Buys Gps is going to pay Handsomely for not Just Cr2/3 in Aml, worth approximately $65 per share, but also CR1, 4X that - and the entire WT1 market -1M Wilms Tumor 1 patients diagnosed each year, across 20 cancer indications.
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 8 at 8:54 PM
$PFE - His expression. Our CEO is a visionary. A clairvoyant. He let us know how 2026 was going to be, during our AGM in April! 🤩
2 · Reply
JBS_84
JBS_84 Jun. 8 at 8:03 PM
$PFE Well I was wrong all day, but I haven't given up
3 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 8 at 8:03 PM
$PFE Of course we close at the absolute low of the day..
2 · Reply
A_Train1
A_Train1 Jun. 8 at 8:00 PM
$PFE trending for the wrong reasons…again
0 · Reply
Outcomes
Outcomes Jun. 8 at 7:50 PM
$IBRX $PFE …..modified mRNA BAD …..’Turbo-cancers’ Save The Children. 🤔 https://x.com/fa21519230/status/2064003496932769833?s=46
1 · Reply
JuggernautRaider
JuggernautRaider Jun. 8 at 7:46 PM
$PFE $CCCC $SLS $TNXP First of all: God Bless Baltimore, AKA “the Charm City”. 💪 Some of my friends call me Big Dave. There’s a funny story behind that. But it does not matter. You can… Call Me Whatever You Want! 😂 God Bless America 🇺🇸 Who will Pfizer buy next? 🤔 💊 🚀 They will always be cutting deals as the only New York City blue blooded pharma left. 🌃 You can call me the Juggernaut Raider. You can call me the Bonesaw of Biopharma. Or you can call me jSizzled - my old xbox name. Maybe i’ll boot it up soon and let one of you TRY to beat me at Madden 😂 Busy at work. Have a blessed week 🙏 GLBB 👍 ☘️ 💊 🐂 Many patients are waiting far too patiently ⏰ More to come. ABC: Always Be Connecting! 😉
3 · Reply
Typecheck
Typecheck Jun. 8 at 7:40 PM
$PFE What is going on? Lily up and NOVO, PFE are down.
1 · Reply
DarkPoolMoney
DarkPoolMoney Jun. 8 at 7:32 PM
$PFE exactly what happens when news comes out that vaccine never worked. Now file is much below it pandemic low. Was a failed vaccine experiment. And all of you were guinea pigs and a failed vaccine experiment.
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jun. 8 at 7:32 PM
$PFE Another glorious day owning Pfizer.
0 · Reply
Latest News on PFE
Pfizer says FDA approves expanded indication for Hympavzi

2026-06-08T10:51:57.000Z - 23 hours ago

Pfizer says FDA approves expanded indication for Hympavzi


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 days ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 days ago

Pfizer Slides: Study update


Mailbag: A Follow-Up on Pfizer & Other Questions

May 30, 2026, 9:22 AM EDT - 9 days ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA


Guardant Health to present 38 abstracts at ASCO 2026 meeting

2026-05-28T12:35:12.000Z - 11 days ago

Guardant Health to present 38 abstracts at ASCO 2026 meeting

GH


Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 4 weeks ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC


Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 4 weeks ago

Pfizer CEO on AI-designed molecule, and race to use new tech


3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 4 weeks ago

3 Dividend Stocks for May 2026

SYY WSO


Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Earnings Call Transcript: Q1 2026


Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Earnings release: Q1 2026


Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Quarterly report: Q1 2026


Pfizer Slides: Q1 2026

May 5, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Slides: Q1 2026


Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 4 weeks ago

Pfizer Posts Better-Than-Expected Revenue, Profit


Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 4 weeks ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS


US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 5 weeks ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN


Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 5 weeks ago

Pfizer's blood cancer drug meets main goal in late-stage trial


Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 28, 2026, 10:17 AM EDT - 5 weeks ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX


Pfizer Transcript: AGM 2026

Apr 23, 2026, 9:00 AM EDT - 6 weeks ago

Pfizer Transcript: AGM 2026


Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 4:45 PM EDT - 6 weeks ago

Pfizer Declares Second-Quarter 2026 Dividend


Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 22, 2026, 5:18 AM EDT - 6 weeks ago

Pfizer GLP-1 weight loss drug available for pre-order in China


The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 7 weeks ago

The Big 3: PFE, V, SYF

SYF V


Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 2 months ago

Big Pharma Is Turning to China for the Newest Drug Ideas


55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 9 at 5:03 AM
$SLS Fact: $ABBV or $PFE or $LLY - whoever Buys Gps is going to pay Handsomely for not Just Cr2/3 in Aml, worth approximately $65 per share, but also CR1, 4X that - and the entire WT1 market -1M Wilms Tumor 1 patients diagnosed each year, across 20 cancer indications.
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 8 at 8:54 PM
$PFE - His expression. Our CEO is a visionary. A clairvoyant. He let us know how 2026 was going to be, during our AGM in April! 🤩
2 · Reply
JBS_84
JBS_84 Jun. 8 at 8:03 PM
$PFE Well I was wrong all day, but I haven't given up
3 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 8 at 8:03 PM
$PFE Of course we close at the absolute low of the day..
2 · Reply
A_Train1
A_Train1 Jun. 8 at 8:00 PM
$PFE trending for the wrong reasons…again
0 · Reply
Outcomes
Outcomes Jun. 8 at 7:50 PM
$IBRX $PFE …..modified mRNA BAD …..’Turbo-cancers’ Save The Children. 🤔 https://x.com/fa21519230/status/2064003496932769833?s=46
1 · Reply
JuggernautRaider
JuggernautRaider Jun. 8 at 7:46 PM
$PFE $CCCC $SLS $TNXP First of all: God Bless Baltimore, AKA “the Charm City”. 💪 Some of my friends call me Big Dave. There’s a funny story behind that. But it does not matter. You can… Call Me Whatever You Want! 😂 God Bless America 🇺🇸 Who will Pfizer buy next? 🤔 💊 🚀 They will always be cutting deals as the only New York City blue blooded pharma left. 🌃 You can call me the Juggernaut Raider. You can call me the Bonesaw of Biopharma. Or you can call me jSizzled - my old xbox name. Maybe i’ll boot it up soon and let one of you TRY to beat me at Madden 😂 Busy at work. Have a blessed week 🙏 GLBB 👍 ☘️ 💊 🐂 Many patients are waiting far too patiently ⏰ More to come. ABC: Always Be Connecting! 😉
3 · Reply
Typecheck
Typecheck Jun. 8 at 7:40 PM
$PFE What is going on? Lily up and NOVO, PFE are down.
1 · Reply
DarkPoolMoney
DarkPoolMoney Jun. 8 at 7:32 PM
$PFE exactly what happens when news comes out that vaccine never worked. Now file is much below it pandemic low. Was a failed vaccine experiment. And all of you were guinea pigs and a failed vaccine experiment.
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jun. 8 at 7:32 PM
$PFE Another glorious day owning Pfizer.
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Jun. 8 at 7:30 PM
$PFE there is that gap fill to 24.44 area on daily chart that gives us this anchor on the action is my thinking.
2 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Jun. 8 at 7:11 PM
$PFE continues to make steady progress on a number of fronts as product lines expand and grow. Position into on weakness imho. Sector still weak and many big names performing poorly today $BMY $REGN $AMGN $BIIB for a few, but number of undervalued big names with solid dividends to boot!
1 · Reply
JBS_84
JBS_84 Jun. 8 at 7:03 PM
$PFE When you see the 5 and 1 minute moving averages line up it's usually a good sign of a reversal.
2 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 8 at 6:39 PM
$PFE - We always join the 💩 sector of the day! We’re magical!
0 · Reply
OnlyFibs
OnlyFibs Jun. 8 at 6:35 PM
$PFE 28C Sep 18 REPEAT SWEEP $28.3K · $0.39/contract · 0.7x Vol/OI Spot $25.65 PFE 4th repeat call sweep targets $28.39 breakeven, 10.7% above spot with 102 DTE, $28.3K premium betting on pharmaceutical upside.
0 · Reply
AFJuvat
AFJuvat Jun. 8 at 6:33 PM
$PFE You mean 38 😀
0 · Reply
A_Train1
A_Train1 Jun. 8 at 6:29 PM
$PFE regain $28 by announcing a new CEO
0 · Reply
JBS_84
JBS_84 Jun. 8 at 6:29 PM
$PFE It will turn around Power hour should bring it back around 26
0 · Reply
AFJuvat
AFJuvat Jun. 8 at 6:13 PM
$PFE It is not the SEC. Just the shittiest company with the shittiest CEO which nobody believes in, anymore.
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Jun. 8 at 6:13 PM
$PFE Pfizer's Obesity Drug Shows 16% Weight Loss In Phase 2b Study BENZINGA Jun-08-2026 2:06 p.m. ET Pfizer Inc. (PFE) shares are trading lower by almost 1% on Monday as the company shared data from Phase 2b studies of berobenatide, an investigational GLP-1 receptor agonist for weight management. Pfizer Berobenatide Update On Saturday, the company reported that the Phase 2b studies for berobenatide demonstrated a non-placebo-adjusted weight loss of 15.9% in participants. The pivotal Phase 3 study is currently open for enrollment, which may further bolster Pfizer’s position in the obesity treatment market. Pfizer (PFE) plans to advance 10 Phase 3 studies for berobenatide in 2026 for chronic weight management and obesity-related comorbidities, including knee osteoarthritis and obstructive sleep apnea, as part of a broader program of 20+ obesity trials. The first clinical experience with the top weekly dose for berobenatide is were presented for the first time.
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 8 at 6:09 PM
$PFE incredible how useless the SEC is
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 8 at 5:57 PM
$PFE miserable..
0 · Reply